Advertisement

Topics

Hollis-Eden Pharmaceuticals Company Profile

11:06 EDT 25th September 2017 | BioPortfolio

Hollis-Eden Pharmaceuticals is a development-stage pharmaceutical company, is engaged in the discovery, development and commercialization of products for the treatment of a number of targeted disease states caused byviral, bacterial, parasitic or fungal infections, including HIV/AIDS, hepatitis B and C, and malaria. The Company has three technology platforms, one based on cellular energy regulation, the second on a unique immune system modulation technology, and the third on biochemical synthesis regulators. The Company believes that certain of its drug candidates may provide the first long-term treatment for HIV without the development of viral strain resistance to the drugs' effectiveness, significant toxicity or severe side effects.

Location

4435 Eastgate Mall
Suite, 400
San Diego
CA
92121
United States of America

Contact

Phone: (858)587-9333
Fax: (858)558-6470
Email: Info@holliseden.com


News Articles [1269 Associated News Articles listed on BioPortfolio]

Author Penelope Colt’s Illustrated the Newly Released “Just What Happened in the Garden of Eden” is a Trio of Biblical Renditions Featuring Adam, Abraham, and Jesus

(PRWEB) May 26, 2017 “Just What Happened in the Garden of Eden”: retells the stories of three Bible figures in modern term...

Two New Innovative Swiss Made EDOF IOLs for Cataract Surgery

The company Swiss Advanced Vision (SAV-IOL SA) announced today the launch of LUCIDIS and EDEN, two new intraocular lenses (IOLs) for the cataract surgery, both using the Instant F...

Minoo H. Hollis, M.D., Orthopedic Surgeon, Joins OrthoAtlanta Stockbridge

ATLANTA, Sept. 21, 2017 /PRNewswire/ -- OrthoAtlanta is pleased to welcome Minoo H. Hollis, M.D., to its orthopedic and sports medicine practice in Stockbridge, Georgia, bringing expertise in foo...

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.

New Website Highlights an Unexpected Effect of a Natural Treatment on HPV Clearance in Infected Individuals

VALLEY COTTAGE, N.Y., May 22, 2017 /PRNewswire/ -- Lilac Corp, the company that sells the natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of a new website. The website exp...

CHF Solutions’ Aquadex FlexFlow® Aquapheresis System Receives FDA IDE Approval for Clinical ...

EDEN PRAIRIE, Minn., June 29, 2017 (GLOBE NEWSWIRE) Read more...

Periodontist, Dr. Andres Sanchez, Makes Dental Implants in Eden Prairie, MN More Attainable

Dr. Andres Sanchez, respected periodontist, now offers two dental implant promotions in order to make it easier for individuals with tooth loss to receive dental implants in Eden Prairie, MN. Eden Pra...

The Center For The Biology Of Chronic Disease Release: Natural Treatment Has An Antibiotic-Like Effect On Viruses; CBCD Reports Publication Of A New Clinical Study Of Gene-Eden-VIR/Novirin

  Life Sciences Jobs   ...

PubMed Articles [165 Associated PubMed Articles listed on BioPortfolio]

Paradise Lost Eden with Leish and Fer-de-Lance.

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Clinical Trials [207 Associated Clinical Trials listed on BioPortfolio]

Clinical Study of Gene-Eden-VIR/Novirin

This study measured the changes in health-related complaints by analyzing charts of individuals, who are infected with a latent virus, who have used Gene-Eden-VIR/Novirin.

Latarjet Versus Modified Eden-Hybinnette for Anterior Shoulder Dislocation

Randomized clinical trial, parallel 1:1, comparing Latarjet to Modified Eden-Hybinnett (iliac bone crest + capsular repair) for recurrent traumatic anterior glenohumeral dislocation.

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1296 Associated Companies listed on BioPortfolio]

Hollis-Eden Pharmaceuticals, Inc.

Hollis-Eden Pharmaceuticals is a development-stage company with two product candidates in clinical trials: Apoptone® (HE3235), in the dose-escalation portion of a Phase I/II trial of patients with la...

Hollis-Eden Pharmaceuticals

Hollis-Eden Pharmaceuticals is a development-stage pharmaceutical company, is engaged in the discovery, development and commercialization of products for the treatment of a number of targeted disease ...

Next-Generation Pharmacist

Civic Leader of the Year: Peter Crouch, RPh, CCP, Eden Drug, Eden, N.C.

Eden Biodesign Ltd.

Eden Biodesign is a globally-integrated biopharmaceutical company offering consultancy, biopharmaceutical design, process development and cGMP manufacturing services to leading bi...

Eden Biodesign

Eden Biodesign is an integrated biopharmaceutical development organisation that evolved out of Eden Biopharm, a successful international development and manufacturing consultancy. Eden Biodesign is th...

More Information about "Hollis-Eden Pharmaceuticals" on BioPortfolio

We have published hundreds of Hollis-Eden Pharmaceuticals news stories on BioPortfolio along with dozens of Hollis-Eden Pharmaceuticals Clinical Trials and PubMed Articles about Hollis-Eden Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hollis-Eden Pharmaceuticals Companies in our database. You can also find out about relevant Hollis-Eden Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...


Corporate Database Quicklinks



Searches Linking to this Company Record